The Front Room — a clinical regulatory commons
RSS
← Back to feed

Furoscix ReadyFlow cleared for edema in heart failure, CKD

Sponsor
MannKind Corporation $MNKD
Drug
Furoscix ReadyFlow · furosemide
Indication
Edema in adults with heart failure or chronic kidney disease
More on MannKind Corporation Google News

FDA approves MannKind's Furoscix ReadyFlow autoinjector for edema in adults with heart failure or chronic kidney disease.

What this means

Furoscix ReadyFlow is a pre-filled, single-use device that delivers the diuretic furosemide under the skin to help remove excess fluid. The FDA cleared this new delivery system for treating swelling in adults with heart failure or chronic kidney disease. This provides a simpler, needle-free option for patients who need this common medication outside of a clinic setting.

Read original at accessdata.fda.gov
Topic Heart failure, CKD

Drug Watch — recent news on Furoscix ReadyFlow